Cargando…
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21)
BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209572/ https://www.ncbi.nlm.nih.gov/pubmed/37231405 http://dx.doi.org/10.1186/s12874-023-01944-2 |
_version_ | 1785046905143689216 |
---|---|
author | Mak, Joyce W. Y. Sun, Yang Limsrivilai, Julajak Abdullah, Murdani Kaibullayeva, Jamilya Balderramo, Domingo Vergara, Beatriz Iade Paudel, Mukesh Sharma Banerjee, Rupa Hilmi, Ida Ali, Raja Affendi Raja Wei, Shu Chen Ng, Ka Kei Altuwaijri, Mansour Kelly, Paul Yamamoto-Furusho, Jesus K. Kotze, Paulo Gustavo Ahuja, Vineet Chong, Vui Heng Dao, Hang Viet Abbey, Yvonne Ching, Jessica Y. L. Ho, Agnes Chan, Alicia K. W. Bernstein, Charles N. Gearry, Richard B. Abreu, Maria Rubin, David T. Dotan, Iris Hracs, Lindsay Kaplan, Gilaad G. Ng, Siew C. |
author_facet | Mak, Joyce W. Y. Sun, Yang Limsrivilai, Julajak Abdullah, Murdani Kaibullayeva, Jamilya Balderramo, Domingo Vergara, Beatriz Iade Paudel, Mukesh Sharma Banerjee, Rupa Hilmi, Ida Ali, Raja Affendi Raja Wei, Shu Chen Ng, Ka Kei Altuwaijri, Mansour Kelly, Paul Yamamoto-Furusho, Jesus K. Kotze, Paulo Gustavo Ahuja, Vineet Chong, Vui Heng Dao, Hang Viet Abbey, Yvonne Ching, Jessica Y. L. Ho, Agnes Chan, Alicia K. W. Bernstein, Charles N. Gearry, Richard B. Abreu, Maria Rubin, David T. Dotan, Iris Hracs, Lindsay Kaplan, Gilaad G. Ng, Siew C. |
author_sort | Mak, Joyce W. Y. |
collection | PubMed |
description | BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. METHODS: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. RESULTS: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. CONCLUSIONS: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-01944-2. |
format | Online Article Text |
id | pubmed-10209572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102095722023-05-26 Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) Mak, Joyce W. Y. Sun, Yang Limsrivilai, Julajak Abdullah, Murdani Kaibullayeva, Jamilya Balderramo, Domingo Vergara, Beatriz Iade Paudel, Mukesh Sharma Banerjee, Rupa Hilmi, Ida Ali, Raja Affendi Raja Wei, Shu Chen Ng, Ka Kei Altuwaijri, Mansour Kelly, Paul Yamamoto-Furusho, Jesus K. Kotze, Paulo Gustavo Ahuja, Vineet Chong, Vui Heng Dao, Hang Viet Abbey, Yvonne Ching, Jessica Y. L. Ho, Agnes Chan, Alicia K. W. Bernstein, Charles N. Gearry, Richard B. Abreu, Maria Rubin, David T. Dotan, Iris Hracs, Lindsay Kaplan, Gilaad G. Ng, Siew C. BMC Med Res Methodol Research BACKGROUND: There is a rapid increase in the incidence of inflammatory bowel diseases (IBD) in newly industrialized countries, yet epidemiological data is incomplete. We herein report the methodology adopted to study the incidence of IBD in newly industrialized countries and to evaluate the effect of environmental factors including diet on IBD development. METHODS: Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) is a population-based cohort of newly diagnosed persons with Crohn’s disease and ulcerative colitis in Asia, Africa, and Latin America to be followed prospectively for 12 months. New cases were ascertained from multiple sources and were entered into a secured online system. Cases were confirmed using standard diagnostic criteria. In addition, endoscopy, pathology and pharmacy records from each local site were searched to ensure completeness of case capture. Validated environmental and dietary questionnaires were used to determine exposure in incident cases prior to diagnosis. RESULTS: Through November 2022, 106 hospitals from 24 regions (16 Asia; 6 Latin America; 2 Africa) have joined the GIVES-21 Consortium. To date, over 290 incident cases have been reported. All patients have demographic data, clinical disease characteristics, and disease course data including healthcare utilization, medication history and environmental and dietary exposures data collected. We have established a comprehensive platform and infrastructure required to examine disease incidence, risk factors and disease course of IBD in the real-world setting. CONCLUSIONS: The GIVES-21 consortium offers a unique opportunity to investigate the epidemiology of IBD and explores new clinical research questions on the association between environmental and dietary factors and IBD development in newly industrialized countries. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-023-01944-2. BioMed Central 2023-05-25 /pmc/articles/PMC10209572/ /pubmed/37231405 http://dx.doi.org/10.1186/s12874-023-01944-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mak, Joyce W. Y. Sun, Yang Limsrivilai, Julajak Abdullah, Murdani Kaibullayeva, Jamilya Balderramo, Domingo Vergara, Beatriz Iade Paudel, Mukesh Sharma Banerjee, Rupa Hilmi, Ida Ali, Raja Affendi Raja Wei, Shu Chen Ng, Ka Kei Altuwaijri, Mansour Kelly, Paul Yamamoto-Furusho, Jesus K. Kotze, Paulo Gustavo Ahuja, Vineet Chong, Vui Heng Dao, Hang Viet Abbey, Yvonne Ching, Jessica Y. L. Ho, Agnes Chan, Alicia K. W. Bernstein, Charles N. Gearry, Richard B. Abreu, Maria Rubin, David T. Dotan, Iris Hracs, Lindsay Kaplan, Gilaad G. Ng, Siew C. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) |
title | Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) |
title_full | Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) |
title_fullStr | Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) |
title_full_unstemmed | Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) |
title_short | Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (GIVES-21) |
title_sort | development of the global inflammatory bowel disease visualization of epidemiology studies in the 21(st) century (gives-21) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209572/ https://www.ncbi.nlm.nih.gov/pubmed/37231405 http://dx.doi.org/10.1186/s12874-023-01944-2 |
work_keys_str_mv | AT makjoycewy developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT sunyang developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT limsrivilaijulajak developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT abdullahmurdani developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT kaibullayevajamilya developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT balderramodomingo developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT vergarabeatriziade developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT paudelmukeshsharma developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT banerjeerupa developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT hilmiida developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT alirajaaffendiraja developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT weishuchen developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT ngkakei developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT altuwaijrimansour developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT kellypaul developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT yamamotofurushojesusk developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT kotzepaulogustavo developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT ahujavineet developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT chongvuiheng developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT daohangviet developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT abbeyyvonne developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT chingjessicayl developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT hoagnes developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT chanaliciakw developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT bernsteincharlesn developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT gearryrichardb developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT abreumaria developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT rubindavidt developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT dotaniris developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT hracslindsay developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT kaplangilaadg developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT ngsiewc developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 AT developmentoftheglobalinflammatoryboweldiseasevisualizationofepidemiologystudiesinthe21stcenturygives21 |